Stay informed with the latest litigation news. Explore now

IP Verse

Anavex Life Sciences competitive analysis

Latest publications and patents of Anavex Life Sciences New

Explore the latest publications and patents granted to Anavex Life Sciences, showcasing their recent innovations and technological advancements.

Last updated on: Sep 6, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Anavex Life Sciences

EP3324956
Nov 20, 2024Enantiomers Of Tetrahydro-N,N-Dimethyl-2,2-Diphenyl-3-Furanmethanamine (Anavex2-73) And Use Thereof In The Treatment Of Alzheimer'S Disease And Other Disorders Modulated By The Sigma 1 ReceptorGranted And Under Opposition
EP3407880
Aug 17, 2022Neurodevelopmental Disorder TherapyOpposition Rejected

Latest patents of Anavex Life Sciences opposed by its competitors

Explore Anavex Life Sciences's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 11, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3324956
Nov 20, 2024Enantiomers Of Tetrahydro-N,N-Dimethyl-2,2-Diphenyl-3-Furanmethanamine (Anavex2-73) And Use Thereof In The Treatment Of Alzheimer'S Disease And Other Disorders Modulated By The Sigma 1 Receptor1
EP3407880
Aug 17, 2022Neurodevelopmental Disorder Therapy1

Latest PTAB cases involving Anavex Life Sciences New

Discover the latest PTAB cases involving Anavex Life Sciences, highlighting their recent legal challenges and patent disputes.

Top competitors of Anavex Life Sciences

Top competitors of Anavex Life Sciences based on patent oppositions.